- increased total body fat amount / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased hemoglobin content / IMPC
- decreased lean body mass / IMPC
- increased circulating glucose level / IMPC
- decreased lymphocyte cell number / IMPC
- decreased locomotor activity / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased neutrophil cell number / IMPC
- increased freezing behavior / IMPC
C57BL/6NTac-Adora2aem2(IMPC)H/H
Status | Available to order |
EMMA ID | EM:12438 |
Citation information | RRID:IMSR_EM:12438 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Adora2aem2(IMPC)H/H |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Adora2aem2(IMPC)H |
Gene/Transgene symbol | Adora2a |
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- heart right ventricle hypertrophy / MGI
- abnormal pulmonary artery morphology / MGI
- increased aggression towards males / MGI
- increased anxiety-related response / MGI
- hypoactivity / MGI
- decreased exploration in new environment / MGI
- abnormal liquid preference / MGI
- abnormal cardiovascular system physiology / MGI
- increased thermal nociceptive threshold / MGI
- increased heart rate / MGI
- abnormal sclera morphology / MGI
- increased systemic arterial blood pressure / MGI
- vascular smooth muscle hypertrophy / MGI
- hypoalgesia / MGI
- myopia / MGI
- abnormal locomotor activation / MGI
- pulmonary hypertension / MGI
- nervous system phenotype / MGI
- abnormal lung vasculature morphology / MGI
- cardiovascular system phenotype / MGI
- vision/eye phenotype / MGI
- decreased cerebral infarction size / MGI
- decreased susceptibility to ischemic brain injury / MGI
- increased body mass index / MGI
- decreased interleukin-10 secretion / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- increased platelet aggregation / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to alcohol / MGI
- increased right ventricle systolic pressure / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).